Search

everythinglearnresearchcommunity

for

Search:↓

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Brodalumab is more effective than ustekinumab in treating psoriasis.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Dupilumab helps children with alopecia areata regrow hair safely.

Enhancing immune response can improve cancer treatment effectiveness.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Talquetamab may cause hair loss and skin issues.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.